Monthly Archives: November 2012

Quebec Increases Refundable SR&ED Tax Credit for Biopharmaceutical Companies

Posted on November 27, 2012 by admin

The Parti Quebecois government has tabled a 2013-2014 fall budget, which has increased the refundable SR&ED tax credit for the biopharmaceutical sector.   The basic refundable tax credit rate of 17.5% will be temporarily increased to 27.5% for eligible biopharmaceutical … Continue reading →

Posted in Changes to SR&ED | Tagged , , , | Leave a comment

Alberta Corporate Tax Amendment Act Introduced to Remove “the Grind” from SR&ED

Posted on November 5, 2012 by admin

Because of the scheduled legislation to remove “the Grind” from Alberta SR&ED claims this fall, the Alberta Corporate Tax Act will be amended to address the forthcoming technical changes.  As a result, AT1 Schedule 9 has been revised and be … Continue reading →

Posted in Changes to SR&ED, Filing for SR&ED | Leave a comment

Reduction of SR&ED Tax Credit Detrimental to Canadian Businesses

Posted on November 5, 2012 by admin

Many of Canada’s largest research and development have voiced their concerns over the federal government’s cuts to the SR&ED program.  According to a report by Canadian Manufacturers and Exporters (CME),  Canadian businesses will receive a $750-million / year reduction in … Continue reading →

Posted in Changes to SR&ED | Tagged | Leave a comment